NG

Naman Gupta

Active Director Director DIN 10341073
DIN 10341073 First appointment Oct 2023 Primary industry Agriculture
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since Oct 2023
Shareholding value •••• Premium profile

About Naman Gupta

Data last updated:

Naman Gupta is a Director at Apn Biotech Private Limited (since 2023), Additional Director at Apn Markcon Private Limited (since 2026) and Director at Avn Buildcon Private Limited (since 2024), and holds 3 more current directorships. The companies operate in Agriculture, Real Estate and Construction and Textile. The 3 current companies with reported revenue have a combined latest revenue of ₹1.66 Cr; the largest is Apn Biotech Private Limited at ₹1.14 Cr (FY 2025).

DIN 10341073
Primary Designation Director
Industry Agriculture
First Appointment 04 Oct 2023
Oldest Company Age 25 yrs
Largest company Apn Biotech Private Limited · ₹1.14 Cr (FY 2025)
Combined revenue ₹1.66 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apn Biotech Private Limited U47721UP2001PTC236931
Director26 Dec 20232001₹1.14 Cr (FY 2025)Active
Apn Markcon Private Limited U47721DL2012PTC232570
Additional Director10 Jan 20262012₹51.4 Lakh (FY 2023)Active
Avn Buildcon Private Limited U45400DL2010PTC205372
Director27 Jun 20242010₹1 Lakh (FY 2024)Active
Apn Markcon Private Limited U47721UW2012PTC257876
Additional Director10 Jan 20262012Active
Designated Partner25 Feb 20252022Active
Craanford Pharma Private Limited U21002UP2023PTC190153
Director04 Oct 20232023Active

Board colleagues of Naman Gupta

NameDINCompanyDesignation
Ashutosh Gupta00443401Apn Biotech Private Limited , Apn Markcon Private Limited and 2 moreDirector
Rishab Jain10678946Avn Buildcon Private LimitedDirector
Ajay Goyal00037052Shreemat Breez LlpDesignated Partner
Jitender Janghu00967195Shreemat Breez LlpDesignated Partner
Madhav Jain10322416Shreemat Breez LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Apn Markcon Private Limited
Shreemat Breez Llp
Avn Buildcon Private Limited
Craanford Pharma Private Limited
Premium access

Shareholding and investment profile for Naman Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naman Gupta

Naman Gupta currently holds 6 directorships: Apn Biotech Private Limited (Director, since 26 Dec 2023, revenue ₹1.14 Cr (FY 2025)); Apn Markcon Private Limited (Additional Director, since 10 Jan 2026, revenue ₹51.4 Lakh (FY 2023)); Avn Buildcon Private Limited (Director, since 27 Jun 2024, revenue ₹1 Lakh (FY 2024)); Apn Markcon Private Limited (Additional Director, since 10 Jan 2026); Shreemat Breez Llp (Designated Partner, since 25 Feb 2025); and 1 more.

Naman Gupta was first appointed on 04 Oct 2023 as Director at Craanford Pharma Private Limited. The most recent appointment on record is 10 Jan 2026 at Apn Markcon Private Limited.

The 3 current companies of Naman Gupta that report revenue have a combined latest revenue of ₹1.66 Cr: Apn Biotech Private Limited ₹1.14 Cr (FY 2025); Apn Markcon Private Limited ₹51.4 Lakh (FY 2023); Avn Buildcon Private Limited ₹1 Lakh (FY 2024).

The current boards of Naman Gupta's companies include Ashutosh Gupta (Apn Biotech Private Limited), Rishab Jain (Avn Buildcon Private Limited), Ajay Goyal (Shreemat Breez Llp), Jitender Janghu (Shreemat Breez Llp), Madhav Jain (Shreemat Breez Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available